Lubin Investment · Screener · Méthodologie

Meilleures actions de qualité du secteur Drug Manufacturers Specialty & Generic

Les actions du secteur Drug Manufacturers Specialty & Generic les mieux notées par notre analyse fondamentale, classées de la meilleure qualité à la moins bonne, avec leur valorisation (P/FCF). Clique sur une action pour son analyse détaillée.

#ActionNote qualitéP/FCF
1Collegium Pharmaceutical Inc (COLL)10/103.8x
2Lantheus Holdings Inc (LNTH)9/1020.1x
3Neurocrine Biosciences Inc (NBIX)9/1027.1x
4Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)9/1048.6x
5Zoetis Inc (ZTS)8/1016.3x
6United Therapeutics Corp (UTHR)8/1026.9x
7Amphastar Pharmaceuticals, Inc (AMPH)8/108.1x
8Kiniksa Pharmaceuticals International PLC (KNSA)8/1029.8x
9ANI Pharmaceuticals Inc (ANIP)8/1012.1x
10Indivior Pharmaceuticals, Inc (INDV)8/1021.9x
11SIGA Technologies Inc (SIGA)7/1012.7x
12Haleon plc (HLN)7/1018.5x
13BioCryst Pharmaceuticals Inc (BCRX)7/109.3x
14Cronos Group Inc (CRON)7/1072.0x
15Pacira Biosciences Inc (PCRX)7/1011.7x
16Teva Pharmaceutical Industries Ltd (TEVA)7/10114.3x
17Liquidia Corp (LQDA)6/10555.8x
18TherapeuticsMD Inc (TXMD)6/1011.3x
19Ironwood Pharmaceuticals Inc (IRWD)6/105.6x
20Biofrontera Inc (BFRI)6/10n.d.
21Esperion Therapeutics Inc (ESPR)6/1017.8x
22HUTCHMED (China) Limited (HCM)6/10n.d.
23Eton Pharmaceuticals Inc (ETON)6/1083.1x
24Xeris Biopharma Holdings Inc (XERS)6/1040.3x
25Hims & Hers Health Inc (HIMS)6/1045.6x
26Divi's Laboratories Limited (DIVISLAB.NS)6/10794.0x
27Apimeds Pharmaceuticals US Inc (APUS)6/10n.d.
28InMed Pharmaceuticals Inc (INM)6/1023.8x
29Kamada Ltd (KMDA)6/1027.8x
30Akebia Therapeutics Inc (AKBA)5/105.4x
31Caring Brands Inc (CABR)5/10n.d.
32Shuttle Pharmaceuticals Holdings Inc (SHPH)5/10n.d.
33Organigram Global Inc. (OGI)5/10n.d.
34Akanda Corp. (AKAN)5/10n.d.
35Optimi Health Corp. (OPTH)5/10n.d.
36SCYNEXIS Inc (SCYX)5/102.5x
37Takeda Pharmaceutical Company Limited (TAK)5/100.1x
38Regencell Bioscience Holdings Limited (RGC)5/10n.d.
39Prestige Consumer Healthcare Inc (PBH)5/109.5x
40Cardiol Therapeutics Inc. (CRDL)5/10n.d.
41Citius Oncology Inc (CTOR)5/10n.d.
42Incannex Healthcare Inc (IXHL)5/10n.d.
43Cipla Limited (CIPLA.NS)5/10130.3x
44Eisai Co., Ltd. (4523.T)5/10151.0x
45Takeda Pharmaceutical Company Limited (4502.T)5/1012.0x
46BioXcel Therapeutics Inc (BTAI)5/10n.d.
47Dr. Reddy's Laboratories Limited (DRREDDY.NS)5/1058.0x
48Aurora Cannabis Inc. (ACB)5/10n.d.
49Dr. Reddy's Laboratories Limited (RDY)5/100.6x
50Gelteq Limited (GELS)5/10n.d.
51IM Cannabis Corp. (IMCC)5/100.3x
52BIOAGE Labs Inc (BIOA)5/10n.d.
53Amylyx Pharmaceuticals Inc (AMLX)5/10n.d.
54Alkermes Plc (ALKS)5/1065.1x
55Anika Therapeutics Inc (ANIK)5/1021.7x
56Rockwell Medical Inc (RMTI)5/106.6x
57Alvotech (ALVO)5/10n.d.
58Amneal Pharmaceuticals Inc (AMRX)5/1021.1x
59Lifecore Biomedical Inc (LFCR)5/1020.5x
60Organogenesis Holdings Inc (ORGO)4/1088.6x

Notre note de qualité juge la solidité du business sur 10 critères financiers objectifs (rentabilité, croissance du free cash flow, rachats d'actions, endettement, rendement du capital). Le P/FCF (prix rapporté au free cash flow) mesure si l'action est chère ou bon marché. Méthode complète : notre méthodologie.

Explorer le screener complet